(Q77058192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

primary biliary cholangitis

0 references

author name string

Chazouillères O

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Wendum D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Serfaty L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Montembault S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Rosmorduc O

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Poupon R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

296-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Chronic active hepatitis with histological features of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

A 33-year-old woman with an autoimmune syndrome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Hepatitis and cholestasis in a middle-aged woman

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

https://api.crossref.org/works/10.1002%2FHEP.510280203

1 reference

7 January 2021

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

The hepatitis-associated bile duct lesion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

A unified concept of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Impaired nonspecific cellular immunity in experimental cholestasis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280203

7 January 2021

Identifiers

DOI

10.1002/HEP.510280203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9695990%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference